Global CMDO VIVEbiotech operates as a GMP CDMO specializing in lentiviral vectors with active Europe and USA collaborations, presenting a ready-made entry point for pharmaceutical and biotech partners seeking scalable manufacturing and development services.

Lentiviral Focus Strength in lentiviral vector production for research, preclinical toxicology, and GMP-grade applications, positioning VIVEbiotech as a preferred partner for gene therapy programs and related viral vector development needs.

Custom Analytical Edge Recent launch of a fully customized analytical framework for in vivo lentiviral vectors creates a cross-sell opportunity for integrated manufacturing plus analytics, reducing timeline risk for clients moving from development to production.

EvoLVcell Expansion Introduction of EvoLVcell signals capacity growth in manufacturing capabilities, enabling conversations with clients about scalable production, batch size optimization, and potential long-term supply agreements.

Strategic Partnerships Ongoing collaborations like the Zelluna relationship and active industry presence via major conferences indicate a strong network; leverage these ties to identify co-development or licensing leads and accelerate deal flow.